associated with increased risk of recurrence and intracranial involvement. METHOD: A retrospective chart-review was completed for all patients diagnosed with scalp or forehead cutaneous scc at a single institution between 1999 and 2009. The diagnosis of scc was confirmed based on pathology reports. Intracranial and/or cavernous sinus involvement was confirmed based on biopsy or imaging. RESULTS: Five male patients with cutaneous scc of the scalp or forehead that developed intracranial metastases were identified. The median age at diagnosis was 68 (53 -89) years. All patients were previously treatment for scc with wide local excision. The average tumor size at diagnosis was 4.9 cm. The mean time from initial diagnosis to intracranial extension was 5.4 months. The most common presenting symptoms were headache, pain, skin paresthesia and imbalance. Patients with cavernous sinus involvement presented with diplopia secondary to abducens nerve palsy. Mean survival time from diagnosis of intracranial involvement with and without cavernous sinus involvement was 3.5 and 9.7 months, respectively. The addition of radiation therapy did not influence disease free or overall survival. CONCLUSION: Cutaneous scalp and forehead scc are highly aggressive. Despite initial treatment with wide local excision and radiation therapy, local recurrence is common. Male gender, age greater than 50, tumor size greater than 2 cm, and moderate to poor or poor histologic differentiation are associated with increased risk of tumor recurrence and intracranial involvement.
Iressa Increases the Sensitivity of NPC Cell Lines to Taxol
Bao Ji-Min (presenter); Sun Jing; Li Zhe; Ma Yun-Peng OBJECTIVE: To investigate apoptosis induced by Iressa in combination with Taxol in nasopharyngeal carcinoma (NPC), and its possible molecular mechanism of action. METHOD: The HNE1 and CNE2 cells were treated by different concentrations of Iressa (2.5, 5, 10 mol/L) combination with Taxol (10 ng/ml) or Taxol alone for 48 h, the apoptosis was examined by Annexin V FITC/PI double-labeled flow cytometry. The expression of p-EGFR, p-AKT, p-STAT3 and TWIST were determined by western blot. RESULTS: In both NPC cell lines, the combined use of Iressa (10 mol/L) and Taxol (10 ng/ml) induced a greater apoptosis rate than Taxol alone (pϭ0.02). Western blotting analysis revealed that combined Iressa and Taxol produced a significant reduction in the levels of phosphorylation of EGFR and STAT3, but Akt remained active. In addition, decreased TWIST protein expression was found in combination treatment groups.
CONCLUSION: Iressa and Taxol had a synergistic effect in NPC cell lines HNE1 and CNE2. The mechanisms underlying these synergistic effects seem possibly via EGFR and STAT3 inhibition.
Laser Surgery for Radiation Failure in Laryngeal Cancer
Kang Dae Lee, PhD (presenter); Sung Won Kim, MD; Young Jin Han, MD; Hyoung Shin Lee, MD; Woo Sung Kim, MD OBJECTIVE: Transoral laser microsurgery(TLM) is successfully performed in the treatment of primary early laryngeal cancer. But few publications deal with the application in patients with recurrent laryngeal cancer after radiation failure. This study aims to review our experience with TLM in these patients.
METHOD:
The records of 24 patients treated by TLM for recurrent laryngeal cancer after curative radiotherapy from 1999 to 2009 were retrospectively analyzed. RESULTS: The distribution of tumor location was glottis 18(rT1, nϭ9; rT2, nϭ9), supraglottis 6(rT1, nϭ2; rT2, nϭ3; rT3, nϭ1). The mean follow-up interval was 51 months in glottic cancer and 54 months in supraglottic cancer. In recurrent glottic cancer, 11 patients were cured with laser procedures. Seven patients could not be controlled by laser surgery: six patients were salvaged by total laryngectomy and one refused further treatment. 3-year local control and 3-year laryngeal preservation rate show better outcomes in rT1 than rT2 (87.5% vs 55.5%, 100% vs 77.8%). There was no difference in 3-year disease specific survival rate for rT1 (100%) and rT2 (100%). Most recurrence after salvage cordectomy was found after 3 years follow up. The mean hospitalized period was 9.6 days after surgery, and tracheotomy was performed in four cases. In recurrent supraglottic cancer, they had no evidence of local recurrence during follow up period. Three patients died of intercurrent disease. CONCLUSION: TLM can be safe and effective salvage procedure for rT1 glottic and selected recurrent supraglottic cancer. Careful patient selection is important in rT2 glottic cancer. Close observation is necessary after 3 years follow up.
Lateral Lymph Node Metastases in Papillary Thyroid Cancer
Neda Ahmadi, MD (presenter); Bruce Davidson, MD; Ameet Grewal, MS OBJECTIVE: Understand the patterns of lateral lymph node metastases in patients with papillary thyroid cancer (PTC) and to compare primary and recurrent necks. METHOD: Retrospective review (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) . RESULTS: Sixty one patients underwent 78 lateral neck dissections for primary (nϭ31) or recurrent (nϭ37) disease (7
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